Auto parts

Duke-NUS marks 20 years with transformative S$30m in philanthropic gifts and pledges to boost next-gen medical breakthroughs

The legacy of Duke-NUS\' founding donor,the Estate of Khoo Teck Puat,continues with a transformative S$5.5 million gift towards research.

01-13

Future Minerals Forum to Announce Major Agreements Worth Billions

RIYADH,Saudi Arabia,Jan. 11,2025-- The highly anticipated fourth edition of the Future Minerals Forum,set to take place from January 14 to 16,2025,in Riyadh,is set to announce big agreements worth bi

01-13 Future Minerals Forum

Bananas hanging onto drones: See how the low-altitude economy matches with agriculture

BEIJING,Jan. 10,2025--A news report from China.org.cn on China\'s low-altitude economy:  

01-13 China.org.cn

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licen

01-13 Menarini Industrie Farmaceutiche Riunite

Tuya Smart Showcases Popular AI Innovations at CES 2025, Defining a New Standard for Future Smart Living

LAS VEGAS,Jan. 10,2025-- Tuya Smart (NYSE: TUYA,HKEX: 2391),a global cloud platform service provider,presented its cutting-edge innovations at CES 2025,which not only showcased numerous cutting-edge t

01-11

Tuya Smart Hosts Successful 'Tuya Developer Day' During CES 2025, Leading Industry Change with Innovative AI Technology

LAS VEGAS,Jan. 10,2025-- Tuya Smart (NYSE: TUYA,HKEX: 2391),a global cloud platform service provider,successfully hosted its highly anticipated Tuya Developer Day event during CES 2025.

01-11

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Jan. 10,2025--Harbour BioMed (HKEX: 02142,the "Company"),a global biopharmaceutical company committed to the discovery,development and com

01-11 Harbour BioMed

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE,England and SAN DIEGO,Jan. 9,2025-- DIOSynVax,a clinical-stage biotechnology company at the forefront of developing innovative,broadly protective vaccines,built on the safety demonstrated by

01-10

OneTrust Expands International Footprint with New Singapore Office

OneTrust grows its presence in APAC to meet regional demand for solutions enabling responsible data and AI use

01-10

Invitation to media and analyst briefing for Ericsson Q4 2024 report

Report to be released at approximately 7:00 AM CET on January 24,2025 One live video webcast for analysts,investors,and journalists at 9:00 AM CET

01-10